Premium Information is available for this item - Upgrade for $1 a day
6625-01-631-1818
Control Test Set
6625016311818 016311818 864442
A test set specifically designed for use in making examinations of controls. View more Control Test Set
January 2023
1

Marketplace 6625-01-631-1818
Request a Quotation from participating marketplace vendors
Related Documents 6625-01-631-1818 2+ Documents (More...)
/fsg-66/fsc-6625/us 6625-01-631-1818 /fsg-66/fsc-6625/us 6625-01-631-1818 /fsg-66/fsc-6625/us 6625-01
-631-1818 /fsg-66/fsc-6625/us 6625-01 -631-1818 /fsg-66/fsc-6625/us 6625-01 -631-1818 /fsg-66/fsc-6625

/fsg-53/fsc-5340/tr
https//www.nsnlookup.com /fsg-53/fsc-5340/tr 5340-27-007-1723 Retaining Clip 5340270071723270071723 E 864442
Control Test Set 6625016311818 016311818 /fsc-6625/us 6625-01 -631-1818 /fsg-66/fsc-6625 https/
Restrictions 6625-01-631-1818
6625-01-631-1818 is a Control Test Set Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.
Import and Export 6625-01-631-1818
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6625-01-631-1818
- Netherlands (ZN01)
- Effective Date:
- 1 Sep 2014
Approved Sources 6625-01-631-1818
- Part Number
- Manufacturer
- Status
- 864442
- Manufacturer
- 34228 - L3 Technologies, Inc. (Active)
- Primary Buy
- Primary Buy
Similar Supply Items to 6625-01-631-1818


















Freight Information 6625-01-631-1818
6625-01-631-1818 has freight characteristics.. 6625-01-631-1818 has a variance between NMFC and UFC when transported by rail and the description should be consulted.